Literature DB >> 1931620

Long term prognosis and quality of life following intensive care for life-threatening complications of haematological malignancy.

E Yau1, A Z Rohatiner, T A Lister, C J Hinds.   

Abstract

Ninety-two consecutive adult patients admitted with acute life-threatening complications of haematological malignancy were studied to determine long term outcome. The quality of life was evaluated in seven long term survivors who are currently alive more than 1 year after hospital discharge using three validated methods: the Nottingham Health Profile, the Hospital Anxiety and Depression Scale and the Perceived Quality of Life Scale. Patients were also asked whether they had returned to work, whether their daily activities were limited and whether they would be willing to undergo intensive care again under the same circumstances. The in-hospital mortality rate was 77%. Median duration of long term survival was 23 months (range 6 weeks to 8 years). Long term survival did not appear to be related to either the aetiology or the severity of the acute illness, but seemed to be determined solely by the nature and progress of the underlying malignancy. The quality of life of six of the seven long term survivors is good, while that of the other is acceptable. None of the patients reported any increased limitation of their daily activities, five had returned to full time employment and all seven stated that they would be willing to undergo intensive care again under the same circumstances.

Entities:  

Mesh:

Year:  1991        PMID: 1931620      PMCID: PMC1977486          DOI: 10.1038/bjc.1991.430

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit.

Authors:  A S Detsky; S C Stricker; A G Mulley; G E Thibault
Journal:  N Engl J Med       Date:  1981-09-17       Impact factor: 91.245

2.  Medical intensive care: indications, interventions, and outcomes.

Authors:  G E Thibault; A G Mulley; G O Barnett; R L Goldstein; V A Reder; E L Sherman; E R Skinner
Journal:  N Engl J Med       Date:  1980-04-24       Impact factor: 91.245

3.  Is intensive care justified for patients with haematological malignancies?

Authors:  F Brunet; J J Lanore; J F Dhainaut; F Dreyfus; J F Vaxelaire; S Nouira; T Giraud; A Armaganidis; J F Monsallier
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

4.  The inverse relationship between cost and survival in the critically ill cancer patient.

Authors:  A D Turnbull; G Carlon; R Baron; W Sichel; C Young; W Howland
Journal:  Crit Care Med       Date:  1979-01       Impact factor: 7.598

5.  Survival, hospitalization charges and follow-up results in critically ill patients.

Authors:  D J Cullen; L C Ferrara; B A Briggs; P F Walker; J Gilbert
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

6.  Respiratory failure in cancer patients.

Authors:  R M Snow; W C Miller; D L Rice; M K Ali
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

7.  Survival of patients with cancer in a medical critical care unit.

Authors:  M J Hauser; J Tabak; H Baier
Journal:  Arch Intern Med       Date:  1982-03

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy.

Authors:  A R Lloyd-Thomas; I Wright; T A Lister; C J Hinds
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

10.  Outcome of respiratory failure in hematologic malignancy.

Authors:  S G Peters; J A Meadows; D R Gracey
Journal:  Chest       Date:  1988-07       Impact factor: 9.410

View more
  12 in total

1.  Quality of life following critical care: moving beyond survival.

Authors:  D K Heyland; D J Kutsogiannis
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

Review 2.  Intensive care.

Authors:  S Sinclair; M Singer
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

3.  Outcome of ICU treatment in invasive aspergillosis.

Authors:  J J Janssen; R J Strack van Schijndel; E H van der Poest Clement; G J Ossenkoppele; L G Thijs; P C Huijgens
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

Review 4.  Patient-reported symptoms and quality of life 
in adults with acute leukemia: a systematic review.

Authors:  Ashley Leak Bryant; AnnMarie Lee Walton; Julia Shaw-Kokot; Deborah K Mayer; Bryce B Reeve
Journal:  Oncol Nurs Forum       Date:  2015-03       Impact factor: 2.172

5.  Overnight sedation with midazolam or propofol in the ICU: effects on sleep quality, anxiety and depression.

Authors:  M Treggiari-Venzi; A Borgeat; T Fuchs-Buder; J P Gachoud; P M Suter
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

6.  Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.

Authors:  S G Oeyen; D D Benoit; L Annemans; P O Depuydt; S J Van Belle; R I Troisi; L A Noens; P Pattyn; J M Decruyenaere
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

7.  Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study.

Authors:  Amanda L Roze des Ordons; Kris Chan; Imran Mirza; Derek R Townsend; Sean M Bagshaw
Journal:  BMC Cancer       Date:  2010-09-28       Impact factor: 4.430

Review 8.  Intensive care and oncology.

Authors:  J P Sculier
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

Review 9.  The prognostic factors for patients with hematological malignancies admitted to the intensive care unit.

Authors:  Qian Cheng; Yishu Tang; Qing Yang; Erhua Wang; Jing Liu; Xin Li
Journal:  Springerplus       Date:  2016-11-29

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.